Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
healthy volunteers/patients
,
castration-resistant prostatic neoplasms
,
pharmacokinetics
,
lymphoma
,
non-hodgkin lymphoma
,
endometrioid carcinoma
,
peritoneal neoplasms
,
hereditary breast and ovarian cancer syndrome
,
malignant mesothelioma
,
mesothelioma
,
pharmacological phenomena
,
digestive system neoplasms
,
urinary bladder neoplasms
,
neuroendocrine tumors
,
islet cell adenoma
,
urogenital neoplasms
,
ovarian neoplasms
,
non-small-cell lung carcinoma
,
endometrial neoplasms
,
prostatic neoplasms
,
ovarian epithelial carcinoma
,
squamous cell carcinoma of head and neck
,
lung neoplasms
,
uterine cervical neoplasms
,
fallopian tube neoplasms
,
colorectal neoplasms
,
postmenopause
,
pancreatic neoplasms
,
small cell lung carcinoma
,
ductal carcinoma
,
stomach neoplasms
,
uterine neoplasms
,
liposarcoma
,
brain neoplasms
,
carcinoma in situ
,
breast diseases
,
urologic neoplasms
,
squamous cell carcinoma
,
serous cystadenocarcinoma
,
adenocarcinoma
,
hereditary sensory and autonomic neuropathies
,
circulating neoplastic cells
,
intraductal carcinoma noninfiltrating
,
syndrome
,
sarcoma
,
head and neck neoplasms
,
female genital neoplasms
,
neoplasms by site
,
transitional cell carcinoma
,
radiosurgery
,
aggression
,
biliary tract neoplasms
,
adenocarcinoma of lung
,
leiomyosarcoma
,
adenosarcoma
,
sex cord-gonadal stromal tumors
,
endometrial stromal sarcoma
,
bone neoplasms
,
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
,
systemic lupus erythematosus
,
precocious puberty
,
polyostotic fibrous dysplasia
,
carcinosarcoma
,
mullerian mixed tumor
,
inborn genetic diseases
,
neutropenia
,
molecular targeted therapy
,
large b-cell lymphoma diffuse
,
salivary gland neoplasms
,
therapeutics
,
myxoid liposarcoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
carcinoma
,
recurrence
,
male breast neoplasms
,
invasive hydatidiform mole
,
disease progression
,
lobular carcinoma
,
ductal carcinoma breast
,
neoadjuvant therapy
,
progression-free survival
,
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
,
neoplasm metastasis
,
multiple endocrine neoplasia type 1
,
eye abnormalities
Eribulin
lymphoma
,
skin neoplasms
,
cutaneous malignant melanoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
renal insufficiency
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
lung neoplasms
,
prostatic neoplasms
,
liposarcoma
,
inflammatory breast neoplasms
,
melanoma
,
leiomyosarcoma
,
urethral neoplasms
,
ureteral neoplasms
,
renal cell carcinoma
,
fallopian tube neoplasms
,
head and neck neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
alopecia
,
pancreatic neoplasms
,
colorectal neoplasms
,
kidney neoplasms
,
pelvic neoplasms
,
colonic neoplasms
,
fatigue
,
circulating neoplastic cells
,
postmenopause
,
soft tissue neoplasms
,
malignant fibrous histiocytoma
,
residual neoplasm
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
hemangioendothelioma
,
osteosarcoma
,
uterine cervical neoplasms
,
salivary gland neoplasms
,
castration-resistant prostatic neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
hepatocellular carcinoma
,
drug therapy
,
triple negative breast neoplasms
,
neoplasms
,
sarcoma
,
neoplasm metastasis
,
carcinoma
,
recurrence
,
non-small-cell lung carcinoma
,
brain neoplasms
,
transitional cell carcinoma
,
urinary bladder neoplasms
,
urologic neoplasms
,
hereditary breast and ovarian cancer syndrome
,
adenocarcinoma
,
brca2 genes
,
invasive hydatidiform mole
,
meningeal neoplasms
,
meningeal carcinomatosis
,
mutation
,
breast neoplasms
,
male breast neoplasms
,
drug-related side effects and adverse reactions
,
neurotoxicity syndromes
,
peripheral nervous system diseases
,
alopecia areata
Eribulin mesylate
breast neoplasms
,
neoplasms
Mycophenolate sodium
healthy volunteers/patients
Docusate
schizophrenia
,
hepatitis c
,
hepatitis
,
hepatitis a
,
viral hepatitis human
,
non-small-cell lung carcinoma
,
lung neoplasms
,
general anesthesia
,
hepatitis b
,
whooping cough
,
herpes zoster
,
mumps
,
tetanus
,
diphtheria
,
measles
,
haemophilus infections
,
chickenpox
,
poliomyelitis
,
rubella
,
migraine disorders
Benzimidazole
healthy volunteers/patients
,
rheumatoid arthritis
,
arthritis
,
drug interactions
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
alzheimer disease
,
prostatic neoplasms
,
carcinoma
,
small cell carcinoma
,
neuroendocrine carcinoma
,
hodgkin disease
,
lymphoma
,
neoplasms
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
hematoma
,
graft rejection
,
atrial fibrillation
,
thrombosis
,
embolism
Sintilimab
non-small-cell lung carcinoma
,
lung neoplasms
Penpulimab
colorectal neoplasms
,
stomach neoplasms
,
pancreatic neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
squamous cell carcinoma of head and neck
,
large b-cell lymphoma diffuse
,
gastrointestinal neoplasms
,
thyroid neoplasms
,
breast neoplasms
,
recurrence
,
neoplasm metastasis
,
sarcoma
,
rectal neoplasms
,
pheochromocytoma
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
small cell lung carcinoma
,
female genital neoplasms
,
glioblastoma
,
uterine cervical neoplasms
,
neoplasms by histologic type
,
triple negative breast neoplasms
,
male breast neoplasms
,
essential tremor
,
head and neck neoplasms
,
syndrome
,
gastrointestinal diseases
,
digestive system diseases
,
paraganglioma
,
osteosarcoma
,
b-cell lymphoma
,
melanoma
,
esophageal neoplasms
,
adenocarcinoma
,
neoadjuvant therapy
,
immunotherapy
,
carcinoma
,
neoplasms
,
lung neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
lymphoma
,
hodgkin disease
,
squamous cell neoplasms
,
hypersensitivity
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
small cell carcinoma
,
thyroid diseases
Lanifibranor
pharmacokinetics
Gilvetmab
prostatic neoplasms
,
small cell carcinoma
,
small cell lung carcinoma
,
adenocarcinoma
,
neuroendocrine tumors
Enoblituzumab
type 1 diabetes mellitus
,
stomach neoplasms
,
type 2 diabetes mellitus
,
diabetes mellitus
,
dyslipidemias
Efbemalenograstim alfa
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
colorectal neoplasms
,
pancreatic neoplasms
,
ovarian neoplasms
,
uterine cervical neoplasms
,
neutropenia
,
breast neoplasms
,
neoplasms
Aglatimagene besadenovec
adenocarcinoma
,
obesity
,
muscular atrophy
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Spartalizumab
glioblastoma
,
cutaneous malignant melanoma
,
neoplasms by histologic type
,
neoplasms by site
,
brain neoplasms
,
gliosarcoma
,
melanoma
,
neoplasms
,
squamous cell carcinoma of head and neck
,
carcinoma
,
breast neoplasms
,
pancreatic neoplasms
,
head and neck neoplasms
,
lung neoplasms
,
sarcoma
,
lymphoma
,
bile duct neoplasms
,
liver neoplasms
,
colonic neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
chordoma
,
non-small-cell lung carcinoma
,
nose neoplasms
Lenograstim
ovarian neoplasms
,
neoplasms
,
sarcoma
,
neuroblastoma
,
central nervous system neoplasms
,
germ cell and embryonal neoplasms
,
liver neoplasms
,
nervous system neoplasms
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use